AI assistant
Sending…
BiomX Inc. — Director's Dealing 2021
Jul 29, 2021
35099_dirs_2021-07-28_e01676e8-f557-4bf6-a139-d999c2e6e89b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-07-26
Reporting Person: Amusa Gbolahan (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-26 | Common Stock, par value $0.0001 | P | 25000 | — | Acquired | 262871 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-26 | Warrants to purchase Common Stock | $5.00 | P | 18750 | Acquired | 2027-01-28 | Common Stock (18750) | Direct |
Footnotes
F1: The reporting person acquired 25,000 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit.
More from BiomX Inc.
Transaction in Own Shares
2026
Jun 5
Board/Management Information
2026
May 28
Interim / Quarterly Report
2026
May 20
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 16
Capital/Financing Update
2026
Apr 13
Regulatory Filings
2026
Apr 10
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 10
Regulatory Filings
2026
Apr 10
Capital/Financing Update
2026
Apr 1